Sf3B1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox gene
| name = Splicing Factor 3b Subunit 1
| symbol = SF3B1
| gene_id = 6762
| omim = 605590
| ensembl = ENSG00000115524
| uniprot = O75533
| chromosome = 2
| location = 2q33.1
| diseases = MDS, CLL, ALS, neurodegeneration
}}
SF3B1 (Splicing Factor 3b Subunit 1) is a gene located on chromosome 2q33.1 that encodes a key component of the U2 small nuclear ribonucleoprotein (snRNP) complex. SF3B1 is essential for pre-mRNA splicing and is one of the most frequently mutated genes in certain cancers, particularly chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes (MDS). The protein plays a critical role in the spliceosome assembly and 3' splice site recognition.
Mutations in SF3B1 have been shown to alter alternative splicing patterns, leading to changes in gene expression that promote tumor progression and resistance to therapy. While primarily studied in cancer, SF3B1 dysfunction may also impact neuronal function through altered splicing of neural transcripts.
SF3B1 encodes splicing factor 3b subunit 1, a core component of the U2 small nuclear ribonucleoprotein (snRNP) complex. SF3B1 is essential for:
SF3B1 is a component of the SF3b complex within the U2 snRNP and interacts with other splicing factors to regulate tissue-specific splicing patterns.
The study of Sf3B1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.